21Aug
08Jan
3Derm announces two FDA Breakthrough Device designations for autonomous skin cancer AI
3Derm Systems, Inc. (3Derm), a leader in the skin imaging and diagnostics industry, announced today that it has been granted two FDA Breakthrough Device designations for 3DermSpot, an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect melanoma, squamous cell carcinoma, and basal cell carcinoma. Read more >>
07Mar
Draper and 3Derm Use Artificial Intelligence to Automate Chronic Skin Disease Management
Draper and 3Derm announced today a collaboration under which the companies will create new automated capabilities for 3Derm's high quality skin imaging systems with the aim of improving the management of chronic inflammatory skin disease, such as psoriasis and eczema. Read more >>
21Nov
Telemedicine Success Often Hinges on Aligning Providers and Payers
Bettano and the health centers first secured a two-year Partnership for Community Health grant to create a teledermatology service at 22 remote sites. They also joined forces with 3Derm, a Boston-based telemedicine company spun out of Yale University in 2013, to provide the store-and-forward technology to enable remote clinics to send dermatology images to a separate site for reading and evaluation. Read more >>
29Jun
3Derm Teledermatology System to Partner with WoundRounds®
3Derm, an innovation leader in teledermatology, today announced a partnership with WoundRounds®, a service of Telemedicine Solutions, LLC (Schaumburg, IL). Read more >>
10Apr